ES8507694A1 - Un procedimiento de ensayo para la deteccion de la presencia de un derivado de fibrina reticulado en un fluido corporal de un animal. - Google Patents

Un procedimiento de ensayo para la deteccion de la presencia de un derivado de fibrina reticulado en un fluido corporal de un animal.

Info

Publication number
ES8507694A1
ES8507694A1 ES84530691A ES530691A ES8507694A1 ES 8507694 A1 ES8507694 A1 ES 8507694A1 ES 84530691 A ES84530691 A ES 84530691A ES 530691 A ES530691 A ES 530691A ES 8507694 A1 ES8507694 A1 ES 8507694A1
Authority
ES
Spain
Prior art keywords
crosslinked fibrin
derivative
monoclonal antibody
antibody
fibrin derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES84530691A
Other languages
English (en)
Spanish (es)
Other versions
ES530691A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fielder Gillespie Davis Ltd
Original Assignee
Fielder Gillespie Davis Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=3770042&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES8507694(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Fielder Gillespie Davis Ltd filed Critical Fielder Gillespie Davis Ltd
Publication of ES530691A0 publication Critical patent/ES530691A0/es
Publication of ES8507694A1 publication Critical patent/ES8507694A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/745—Assays involving non-enzymic blood coagulation factors
    • G01N2333/75—Fibrin; Fibrinogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Public Health (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Engineering & Computer Science (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ES84530691A 1983-03-17 1984-03-16 Un procedimiento de ensayo para la deteccion de la presencia de un derivado de fibrina reticulado en un fluido corporal de un animal. Expired ES8507694A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPF849483 1983-03-17

Publications (2)

Publication Number Publication Date
ES530691A0 ES530691A0 (es) 1985-09-01
ES8507694A1 true ES8507694A1 (es) 1985-09-01

Family

ID=3770042

Family Applications (1)

Application Number Title Priority Date Filing Date
ES84530691A Expired ES8507694A1 (es) 1983-03-17 1984-03-16 Un procedimiento de ensayo para la deteccion de la presencia de un derivado de fibrina reticulado en un fluido corporal de un animal.

Country Status (18)

Country Link
US (1) US4758524A (OSRAM)
EP (1) EP0122478B2 (OSRAM)
JP (1) JPS59183696A (OSRAM)
KR (1) KR840008288A (OSRAM)
AT (1) ATE99738T1 (OSRAM)
AU (1) AU572125B2 (OSRAM)
CA (1) CA1247022A (OSRAM)
DE (1) DE3486262T3 (OSRAM)
DK (1) DK158284A (OSRAM)
ES (1) ES8507694A1 (OSRAM)
GR (1) GR81951B (OSRAM)
IL (1) IL71264A (OSRAM)
IN (1) IN158324B (OSRAM)
NO (1) NO167338C (OSRAM)
NZ (1) NZ207459A (OSRAM)
PH (1) PH22957A (OSRAM)
PT (1) PT78267B (OSRAM)
ZA (1) ZA841878B (OSRAM)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4722903A (en) * 1983-11-14 1988-02-02 New York Blood Center, Inc. Monoclonal antibodies specific to in vivo fragments derived from human fibrinogen, human fiberin I or human fibrin II
DE3400434A1 (de) * 1984-01-09 1985-09-26 Behringwerke Ag, 3550 Marburg Bestimmung von fibrin mit fibrin-spezifischen antikoerpern
JPS60166698A (ja) * 1984-02-09 1985-08-29 Dai Ichi Pure Chem Co Ltd モノクロ−ナル抗体
US5357042A (en) * 1984-04-23 1994-10-18 The General Hospital Corporation Synthetic peptides capable of eliciting fibrin-specific monoclonal antibodies lacking fibrinogen-cross-reactivity
US4927916A (en) * 1984-04-23 1990-05-22 The General Hospital Corporation Method of producing fibrin-specific monoclonal antibodies lacking fibrinogen-cross-reactivity using fibrin-specific peptides
FR2569276B1 (fr) * 1984-08-14 1988-02-05 Stago Diagnostica Procede de dosage de produits de degradation du fibrinogene
US5116613A (en) * 1985-01-08 1992-05-26 The General Hospital Corporation Antibody-thrombolytic agent product and method of use
US4775624A (en) * 1985-02-08 1988-10-04 Eli Lilly And Company Vectors and compounds for expression of human protein C
FR2593518B1 (fr) * 1985-05-02 1989-09-08 Transgene Sa Vecteurs d'expression et de secretion de l'hirudine par les levures transformees
US4916070A (en) * 1986-04-14 1990-04-10 The General Hospital Corporation Fibrin-specific antibodies and method of screening for the antibodies
JPH0746104B2 (ja) * 1986-09-22 1995-05-17 株式会社ヤトロン Ｆｄｐの測定法
FI89634C (fi) * 1987-07-10 1993-10-25 Yamanouchi Pharma Co Ltd Foerfarande, anordning och kitt foer maetning av vaevnadsplasminogenaktivator-aktivitet
US5372812A (en) * 1988-04-04 1994-12-13 The General Hospital Corporation Composition and method for acceleration of clot lysis
US5582862A (en) * 1988-04-04 1996-12-10 General Hospital Corporation Antibodies that bind to α2-antiplasmin crosslinked to fibrin which do not inhibit plasma α2-antiplasmin
US5120834A (en) * 1988-06-13 1992-06-09 American Biogenetic Sciences, Inc. Fibrin-specific monoclonal antibody
US5453359A (en) * 1988-06-13 1995-09-26 American Biogenetic Sciences, Inc. Immunoassay and kit for in vitro detection of soluble DesAABB fibrin polymers
US5206140A (en) * 1988-06-24 1993-04-27 Research Corporation Technologies, Inc. Assay for soluble crosslinked fibrin polymers
IE67430B1 (en) * 1988-06-24 1996-04-03 Res Corp Technologies Inc Assay for soluble crosslinked fibrin polymers
US5609869A (en) * 1988-08-19 1997-03-11 The General Hospital Corporation Hybrid immunoglobulin-thrombolytic enzyme molecules which specifically bind a thrombus, and methods of their production and use
US5811265A (en) * 1988-08-19 1998-09-22 The General Hospital Corporation Hybrid immunoglobulin-thrombolytic enzyme molecules which specifically bind a thrombus, and methods of their production and use
CA2023354C (en) * 1989-08-17 2002-08-13 Karen Ann Thomas Method for direct chemical binding of d-dimer from a biological sample for diagnosing and monitoring thrombolytic and hypercoagulable states
EP0489061A4 (en) * 1989-08-24 1992-10-14 Australian Nuclear Science And Technology Organisation Radio-labelled antibodies for imaging
FR2663748B1 (fr) * 1990-06-22 1992-10-09 Oris Ind Cie Anticorps specifiques de la liaison isopeptidique induite par les transglutaminases, antigenes constitues par des isopeptides glu-lys reconnus par lesdits anticorps, agents de diagnostic et compositions therapeutiques les contenant.
US5807535A (en) * 1992-07-31 1998-09-15 Australian Nuclear Science & Technology Organisation Metal complexes of hydroxyaryl containing aminocarboxylic acid chelating agents
DE69327760T2 (de) * 1992-07-31 2000-09-07 Australian Nuclear Science And Technology Organisation, Lucas Heights Hydroxyaryl enthaltenden aminocarboxylsäure-chelatbildnern
US5487892A (en) * 1994-02-24 1996-01-30 American Biogenetic Sciences, Inc. Method for treating thrombotic disease using a fibrin specific monoclonal antibody
EP0941345A2 (en) * 1996-09-20 1999-09-15 The General Hospital Corporation Chimeric, humanized and single chain antibodies to alpha-2-antiplasmin
US20020106708A1 (en) * 2000-11-13 2002-08-08 Sigma-Aldrich Co. Assays reagents and kits for detecting or determining the concentration of analytes
WO2002046769A2 (en) * 2000-12-05 2002-06-13 The Penn State Research Foundation A monoclonal antibody-based diagnostic assay for gamma fibrinogen
BR0210648A (pt) * 2001-06-26 2004-10-05 Agen Biomedical Ltd Variante de uma molécula imunointerativa, anticorpo monoclonal, forma disimunizada de anticorpo monoclonal 3b6, método para a geração de um anticorpo monoclonal desimunizado, molécula de anticorpo desimunizada, anticorpo desimunizado, anticorpo monoclonal de murino variante 3b6 desimunizado, variante de um anticorpo monoclonal de murino 3b6 desimunizado para uso em humanos, método para a detecção de um coágulo sanguìneo em um paciente humano, método para a detecção de um coágulo sanguìneo ou de um seu fragmento de ligação a antìgeno, método para a facilitação da dissolução ou da remoção de um coágulo sanguìneo em um humano, uso de um anticorpo monoclonal derivado de murino variante, e, conjugado
US20040001848A1 (en) * 2002-03-01 2004-01-01 Szu-Yi Chou Method of producing disease-specific antigens
US7485438B2 (en) * 2002-03-01 2009-02-03 Szu-Yi Chou Method of producing polyvalent antigens
US20030219853A1 (en) * 2002-03-01 2003-11-27 Szu-Yi Chou Method of cross-linking a compound
US20030224476A1 (en) * 2002-03-01 2003-12-04 Szu-Yi Chou Method of producing transglutaminase reactive compound
DE102004052082A1 (de) 2004-10-26 2006-04-27 Dade Behring Marburg Gmbh Durchstoßbare, flexible Vorrichtung zur Abdeckung von Flüssigkeitsbehältnissen
US11506674B2 (en) 2005-07-29 2022-11-22 Princeton Biomeditech Corporation Monoclonal antibody against D-dimer and diagnosis agent for detecting D-dimer, crosslinked fibrin and its derivatives containing D-dimer by using the antibody
US12429488B2 (en) 2005-07-29 2025-09-30 Princeton Biomeditech Corporation Monoclonal antibody against D-dimer and diagnosis agent for detecting D-dimer, crosslinked fibrin and its derivatives containing D-dimer by using the antibody
US8940489B2 (en) * 2005-07-29 2015-01-27 Hyun-Ju Doh Monoclonal antibody against D-dimer and diagnosis agent for detecting D-dimer, crosslinked fibrin and its derivatives containing D-dimer by using the antibody
ES2655099T3 (es) * 2010-04-01 2018-02-16 Lsi Medience Corporation Nuevos anticuerpos monoclonales y procedimiento de análisis inmunológico del dímero D
WO2012014996A1 (ja) 2010-07-30 2012-02-02 シスメックス株式会社 Ｆｄｐ測定用試薬及び試薬キット、並びに測定方法
TWI658268B (zh) * 2017-11-29 2019-05-01 國立清華大學 血液檢測方法
EP4130036A4 (en) * 2020-03-30 2024-05-15 National Cancer Center Antibody drug conjugate

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4196265A (en) * 1977-06-15 1980-04-01 The Wistar Institute Method of producing antibodies
JPS59155762A (ja) * 1982-12-06 1984-09-04 フイ−ルダ−・ジルレスピ−・デイビス・リミテツド フイ−ルドイムノアツセイ反応システムおよび方法
AU2373384A (en) * 1982-12-06 1984-06-14 Fielder Gillespie Davis Ltd. Field immunoassay reaction system
US4722903A (en) * 1983-11-14 1988-02-02 New York Blood Center, Inc. Monoclonal antibodies specific to in vivo fragments derived from human fibrinogen, human fiberin I or human fibrin II

Also Published As

Publication number Publication date
ES530691A0 (es) 1985-09-01
AU572125B2 (en) 1988-05-05
PH22957A (en) 1989-02-03
GR81951B (OSRAM) 1984-12-12
EP0122478A2 (en) 1984-10-24
KR840008288A (ko) 1984-12-14
EP0122478A3 (en) 1987-04-01
US4758524A (en) 1988-07-19
EP0122478B1 (en) 1994-01-05
IL71264A0 (en) 1984-06-29
DE3486262T2 (de) 1994-06-16
EP0122478B2 (en) 2000-04-12
NO167338B (no) 1991-07-15
IN158324B (OSRAM) 1986-10-18
DE3486262T3 (de) 2000-10-26
JPS59183696A (ja) 1984-10-18
NO167338C (no) 1993-12-15
DK158284D0 (da) 1984-03-16
ATE99738T1 (de) 1994-01-15
DE3486262D1 (de) 1994-02-17
AU2538784A (en) 1984-09-20
NZ207459A (en) 1987-11-27
CA1247022A (en) 1988-12-20
IL71264A (en) 1987-10-20
DK158284A (da) 1984-09-18
NO841023L (no) 1984-09-18
PT78267B (en) 1986-04-21
JPH0583240B2 (OSRAM) 1993-11-25
ZA841878B (en) 1984-10-31
PT78267A (en) 1984-04-01

Similar Documents

Publication Publication Date Title
ES8507694A1 (es) Un procedimiento de ensayo para la deteccion de la presencia de un derivado de fibrina reticulado en un fluido corporal de un animal.
CA1270194A (en) Method for enhancing and/or accelerating immunoassay detection of human carcinoma tumor associated antigen in a pathology sample
NO166465C (no) Fremgangsmaate for bestemmelse av sekvensen av monomerer.
JPS60188095A (ja) 受容部または目標部を形成する化学標識されたｄｎａおよびその他の生物学的物質を検出するための不均質系
US4379839A (en) Method for detecting cancer
AU3615384A (en) Method of detecting immiune complexes in serium
EP0314402A3 (en) Monoclonal antibodies against human interleukin-4 and hybridomas producing the same
Kähne et al. Alterations in structure and cellular localization of molecular forms of DP IV/CD26 during T cell activation
ATE152244T1 (de) Verfahren zur herstellung von imunodiagnose- mitteln
Ebstein et al. A radioimmunoassay of human circulatory dopamine-β-hydroxylase
SE8100011L (sv) Detektering av cancerceller
EP0585960A3 (en) Diagnostic method for autoimmune diseases
ATE44621T1 (de) Proteinkonjugate von penicillosaeure, ihre herstellung und verwendung.
DE3667061D1 (en) New protein isolated from blood, process for preparing said protein, antibodies against said new protein, and pharmaceutical compositions containing said protein or said antibodies
DE69033352D1 (de) Competitives enzym-testverfahren zum nachweis von phosphothioaten
Olivo et al. Presence of antigen B from Taenia solium cysticercus in other platyhelminthes
JPS55152458A (en) Method of eliminating immunoreaction interference in immunological measurement method
EP0220702A3 (en) Method for the preparation of monoclonal antibody derived from immunoreactive trypsin
DE3569161D1 (en) Process for assaying atl virus antibody and reagent therefore
JPS6488368A (en) Method for measuring complex of urokinase and urokinase inhibitor
EP0207979A4 (en) IMMUNOLOGICAL METHOD FOR MEASURING UNSTABLE ANALYTES USING CROSS-REACTIVE ANTIBODIES.
US4442088A (en) Tumor enzyme detection
JPS6415659A (en) Method for measuring human placental alkali phosphatase
Sandberg et al. Stimulation of prostaglandin synthesis with resultant bone resorption by the classical and alternative C pathways
JPS5270017A (en) Novel method for immono-assay

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20050510